The Barcelona Clínic Liver Cancer (BCLC) group, within the framework of the Clínic Barcelona Comprehensive Cancer Center —a center promoted by Clín...
Researchers from Clínic-IDIBAPS have participated in a Lancet Commission with international experts highlighting that more than 60% of liver cancer...
The European Association for the Study of the Liver (EASL) has published an update of its guidelines for the management of hepatocellular carcinoma...
A team of researchers from the Clínic-IDIBAPS have analysed the capacity of an artificial intelligence model to classify liver lesions after a magn...
Hepatocellular carcinoma is the most common primary liver tumor and is currently one of the leading causes of cancer-related mortality. In most cas...
